Stock since the trade +4.2% · S&P 500 -1.6% · to Oct 1Traded 14 days after resultsStock 26% above its 52-week low and 5% below its high
107K → 74K shares held−31% of their stake
ABBV · NYSE · Pharmaceuticals
Stock since the trade +4.2% · S&P 500 -1.6% · to Oct 1Traded 14 days after resultsStock 26% above its 52-week low and 5% below its high
107K → 74K shares held−31% of their stake
AbbVie's CHIEF BUS/STRAT OFFICER sold $8.18M of AbbVie shares. Nobody planned it ahead of time.
Officer plans to sell ~$8.18M of AbbVie
Planned, from payStock since the trade +10.1% · S&P 500 +11.5% · to Oct 1Traded 28 days after resultsStock within 4% of its 52-week high, after a 10% rise in the previous month
7,884 → 2,654 shares held−66% of their stake
AbbVie's SVP, Controller sold $1.22M of AbbVie shares. Nobody planned it ahead of time.
Stock since the trade +11.0% · S&P 500 +11.3% · to Oct 1Traded 26 days after resultsStock within 5% of its 52-week high
18K → 7,219 shares held−59% of their stake
AbbVie's GC AND SECRETARY sold $2.41M of AbbVie shares. Nobody planned it ahead of time.
Stock since the trade +11.0% · S&P 500 +11.3% · to Oct 1Traded 26 days after resultsStock within 5% of its 52-week high
23K → 18K shares held−25% of their stake
AbbVie's GC AND SECRETARY sold $1.35M of AbbVie shares. Nobody planned it ahead of time.
Stock since the trade +11.0% · S&P 500 +11.3% · to Oct 1Traded 26 days after resultsStock within 5% of its 52-week high
7,219 → 4,619 shares held−36% of their stake
AbbVie's GC AND SECRETARY sold $612K of AbbVie shares. Nobody planned it ahead of time.
Stock since the trade +14.6% · S&P 500 +10.2% · to Oct 1Traded 21 days after resultsStock 33% above its 52-week low and 7% below its high
61K → 38K shares held−37% of their stake
AbbVie's GC AND SECRETARY sold $5.15M of AbbVie shares. Nobody planned it ahead of time.